Sub-30 Second Disintegration
Formulated with specialized croscarmellose and microcrystalline matrices that dissolve smoothly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.
DELOTRIL-2 is a maximum-strength Clonazepam Mouth Dissolving Tablets IP 2 mg formulation by Blessme, the dedicated neuro-psychiatric division of Dellwich Lifescience LLP. Formulated with fast-melt oral disintegration technology, DELOTRIL-2 provides rapid sublingual dissolution without water, delivering maximum-potency anticonvulsant and anti-panic stabilization for tertiary hospitals and PCD franchise partners across India.

Detailed pharmaceutical specifications, active API monograph compliance, fast-melt characteristics, and packaging details for DELOTRIL-2.
Clonazepam Mouth Dissolving Tablets IP 2 mg (DELOTRIL-2) is a maximum clinical strength benzodiazepine oral formulation engineered to dissolve rapidly on the tongue without water. Provides robust control for refractory epilepsy, severe status-related seizure management, and extreme panic crises under expert medical supervision.
Comprehensive clinical and commercial guide on Clonazepam Mouth Dissolving Tablets IP 2 mg, marketed as DELOTRIL-2 by Blessme (Dellwich Lifescience LLP). Features receptor neurochemistry, refractory epilepsy management, comparative dosing, and B2B pharmaceutical distribution across India.
Clonazepam MD tablet 2 mg is the highest standard oral clinical strength of Clonazepam IP formulated in an advanced orally disintegrating matrix. It is prescribed when maximum antiepileptic potency and deep GABAergic inhibition are required to suppress refractory seizure activity or incapacitating panic crises.
During neurological seizure clusters or post-ictal states, patients may suffer from impaired swallowing or motor coordination. DELOTRIL-2 dissolves smoothly on the tongue within 30 seconds upon contact with saliva, initiating fast mucosal uptake and clinical tranquilization without liquid administration.
Clonazepam MD tablet uses for the 2 mg strength focus on complex, high-severity neurological and psychiatric conditions:
Clonazepam 2 mg acts as a high-potency positive allosteric modulator on the GABAA receptor complex in the central nervous system. By enhancing the binding of gamma-aminobutyric acid (GABA), it increases the opening frequency of chloride ion channels, causing significant hyperpolarization of neuronal membranes.
This mechanism suppresses paroxysmal electrical firing in the epileptogenic focus, subcortical pacemakers, and thalamocortical networks. The Mouth Dissolving (MD) formulation allows a portion of the drug to be absorbed sublingually and buccally, facilitating rapid systemic entry and symptom relief during intense clinical emergencies.
The DELOTRIL portfolio provides tiered therapeutic options for individual patient requirements:
DELOTRIL-2 must be administered under strict medical supervision:
Among established brands in India (Clonafit, Zapiz, Epitril), DELOTRIL-2 by Blessme has earned clinical trust for its reliability and commercial value:
Essential clinical warnings for healthcare professionals and patients:
Clonazepam 2 mg is a maximum-strength benzodiazepine with significant potential for habit formation, tolerance, and physical dependence. Long-term use requires careful clinical monitoring. DELOTRIL-2 is supplied strictly against a valid medical prescription from a registered medical practitioner.
DELOTRIL-2 is manufactured in advanced automated pharmaceutical facilities adhering to WHO-GMP, ISO 9001:2015, and Schedule M standards, ensuring exceptional fast-melt uniformity and batch-to-batch consistency.
Formulated with specialized croscarmellose and microcrystalline matrices that dissolve smoothly on the tongue within 30 seconds, enabling fast mucosal uptake without swallowing discomfort.
Encased in 5x4x10 protective blister cavities that insulate the hygroscopic fast-melt tablet from ambient atmospheric moisture, heat, and physical crumbling.
Strict pharmacopoeial monograph assays confirm precise 2 mg Clonazepam IP content, rapid disintegration limits, and dissolution conformity batch after batch.
Produced in state-of-the-art clean-room compression suites adhering to WHO-GMP, ISO 9001:2015, and Good Laboratory Practices (GLP) with automated environmental controls.
As a Schedule H controlled benzodiazepine medication, Clonazepam MD requires responsible clinical oversight, patient counseling, and adherence to prescription mandates.
DELOTRIL-2 contains Clonazepam IP 2 mg. To be sold by retail on the prescription of a Registered Medical Practitioner only. Do not exceed prescribed duration. Caution is advised when driving motor vehicles or handling complex machinery.
Approved neurological and psychiatric indications for Clonazepam MD 2 mg (DELOTRIL-2):
Key pharmacokinetic parameters and patient monitoring guidelines:
Dellwich Lifescience LLP is an established pharmaceutical company based in Science City, Ahmedabad, Gujarat, dedicated to advanced formulation technology, uncompromising quality assurance, and ethical healthcare supply. Through our specialized neurology division, Blessme, we manufacture and market superior neuro-psychiatric treatments, including DELOTRIL-2 (Clonazepam MD Tablets IP 2 mg).
We support PCD pharma franchise partners, hospital supply chains, and contract manufacturing clients across India with guaranteed supply security, validated product dossiers, and prompt dispatch.
Whether you are seeking DELOTRIL-2 (Clonazepam MD Tablets IP 2 mg) for district monopoly PCD franchise distribution, third-party contract manufacturing, or hospital bulk procurement, Dellwich Lifescience LLP delivers dependable supply and competitive trade margins.
Secure exclusive district-level distribution rights for DELOTRIL-2 and the entire Blessme Neuro portfolio with promotional visual aids, doctor samples, and attractive trade margins.
Contract manufacturing solutions for Clonazepam MD tablets (0.25 mg, 0.5 mg, 1 mg, 2 mg) with custom batch sizing, stability dossier preparation, and fast delivery timelines.
Direct supply partnerships for psychiatric hospitals, neuropsychiatric clinics, de-addiction centers, and state government health tenders across India.
When sourcing Clonazepam MD tablets IP or evaluating dependable clonazepam mouth dissolving tablet brands in India, DELOTRIL-2 by Blessme provides exceptional quality, rapid disintegration, and comprehensive B2B support.
Manufactured in WHO-GMP and ISO 9001:2015 certified units using pharmacopoeial grade Clonazepam IP, guaranteeing assay precision and fast-melt integrity.
Tamper-evident, moisture-resistant 5x4x10 blister strips protect fragile mouth-dissolving tablets from ambient humidity and transit friction.
Direct factory dispatch from Science City, Ahmedabad with GST invoicing, verified batch COA, and dependable logistics coverage across all Indian states.
Exclusive district-level franchise rights for DELOTRIL-2 and the entire Blessme Neuro portfolio with promotional tools, visual aids, and MR bags.
Certificates of Analysis (COA), stability testing data, and Material Safety Data Sheets (MSDS) readily available for institutional tenders and hospital audits.
Direct access to Dellwich Lifescience LLP product specialists for quick quotes, customized bulk supply inquiries, and dedicated customer assistance.
Authoritative answers to clinical, commercial, dosage, and regulatory questions regarding Clonazepam MD Tablets IP 2 mg.
Clonazepam MD tablet 2 mg (marketed under the brand name DELOTRIL-2 by Blessme division of Dellwich Lifescience LLP) is a maximum clinical strength orally disintegrating benzodiazepine formulation. Each tablet contains Clonazepam IP 2 mg, engineered to dissolve rapidly on the tongue without water, providing fast sublingual and mucosal absorption for refractory epileptic seizures, severe agoraphobia, and acute psychiatric crises.
DELOTRIL-2 is indicated in specialized neurology and psychiatry for: (1) refractory epilepsy including akinetic, myoclonic, and atypical absence seizures; (2) Lennox-Gastaut syndrome in children and adults; (3) severe, incapacitating panic disorder and agoraphobia unresponsive to lower strengths; and (4) acute psychiatric agitation or catatonia under specialist medical oversight.
In seizure disorders and severe panic crises, patients may experience impaired motor control, tremors, or post-ictal drowsiness that make swallowing tablets with water hazardous. DELOTRIL-2 melts on the tongue in under 30 seconds upon contact with saliva, allowing prompt and safe administration without choking hazards.
DELOTRIL-1 contains 1 mg Clonazepam IP, used for moderate-to-severe panic disorder and standard epilepsy regimens. DELOTRIL-2 contains 2 mg Clonazepam IP, providing double the therapeutic potency for refractory seizure clusters, status-related maintenance, and severe psychiatric agitation requiring higher dosage thresholds.
Clonazepam 2 mg acts as a high-potency positive allosteric modulator on post-synaptic GABA_A receptor-chloride ion channel complexes throughout the brain. By enhancing the inhibitory action of gamma-aminobutyric acid, it stimulates massive inward chloride flux, deeply hyperpolarizing neuronal membranes and abruptly extinguishing epileptogenic foci and acute panic discharge circuits.
No. Clonazepam 2 mg is strictly categorized as a Schedule H prescription drug and controlled psychotropic substance in India. DELOTRIL-2 can only be dispensed against a valid prescription issued by a registered medical practitioner.
DELOTRIL-2 is packaged in high-barrier 5x4x10 blister strips (200 tablets per box) manufactured with moisture-impermeable foils that protect the delicate fast-melt matrix from tropical ambient humidity and transit vibration.
DELOTRIL-2 is manufactured under WHO-GMP compliance and marketed by Dellwich Lifescience LLP, headquartered in Science City, Ahmedabad, Gujarat, under its dedicated neurology and psychiatry portfolio 'Blessme Neuro Products'.
Yes. Dellwich Lifescience LLP provides exclusive district monopoly PCD pharma franchise opportunities for DELOTRIL-2 and the complete Blessme Neuro and Psychiatric range, complete with promotional visual aids, product catalogs, MR bags, and prompt delivery.
Place the tablet directly on the tongue until it dissolves in saliva, then swallow. No water is needed. In epilepsy, adult dosage is carefully titrated from lower doses up to 2 mg taken 2 to 3 times daily, not exceeding maximum physician-prescribed limits. Discontinuation must be carried out by slow, gradual tapering.
Due to its high potency, significant sedation, motor clumsiness, ataxia, and muscular relaxation are expected. Patients must not drive or operate machinery. Chronic usage leads to tolerance and physical dependence, mandating strict medical supervision.
DELOTRIL-2 is priced competitively with high B2B distributor margins. For official trade rate lists, PCD franchise terms, and institutional hospital supply quotes, contact Dellwich Lifescience LLP at +91-9909931992 or [email protected].
Yes. Dellwich Lifescience LLP offers third-party and loan license manufacturing for Clonazepam MD tablets across 0.25 mg, 0.5 mg, 1 mg, and 2 mg strengths in WHO-GMP certified facilities with complete stability validation.
Yes. Every batch of DELOTRIL-2 is accompanied by an authenticated Certificate of Analysis (COA), disintegration assay records, active IP testing, and Material Safety Data Sheet (MSDS).
Connect directly with Dellwich Lifescience LLP for trade pricing, district monopoly PCD rights, third-party manufacturing, or institutional hospital tender supplies.
Get bulk pricing, PCD monopoly availability, and technical documentation for Clonazepam MD 2 mg.